T CELL MALIGNANCIES
Clinical trials for T CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new T CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for T CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat blood cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called ELA026 for adults with advanced T cell cancers that have returned or haven't responded to previous treatments. Researchers will first determine safe dosage levels, then expand to more participants to see how well the drug works.…
Matched conditions: T CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
New immune cell therapy targets aggressive blood cancers in kids and adults
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy called CD7 CAR T-cells for patients with T-cell blood cancers that have returned or not responded to other treatments. The therapy involves collecting a patient's own immune cells or using donor cells, modifying…
Matched conditions: T CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New 'Living Drug' trial targets aggressive blood cancers in kids and adults
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy called CD5 CAR-T for people with T-cell cancers that have come back or not responded to other treatments. Doctors will modify a patient's own immune cells (or cells from a donor) to better target and fight the cancer. …
Matched conditions: T CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for incurable blood cancers: experimental CAR-T therapy enters trial
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy, called CD5-CAR T cells, for people with aggressive T-cell blood cancers that have come back or not responded to standard treatments. The main goals are to find a safe and effective dose and to see if the therap…
Matched conditions: T CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC